UB Paderborn / Katalog / Suche / in CDI

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Journal of internal medicine, 2015-06, Vol.277 (6), p.717-726

2015

Volltextzugriff (PDF)

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2024-02, Vol.14 (1), p.3704-3704, Article 3704

2024

Volltextzugriff (PDF)

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Mucosal immunology, 2016-11, Vol.9 (6), p.1455-1465

2016

Volltextzugriff (PDF)

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2019-01, Vol.9 (1), p.167

2019

Volltextzugriff (PDF)

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

Transplant international, 2023, Vol.36, p.11729-11729

2023

Volltextzugriff (PDF)

Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1948-1954

2022

Volltextzugriff (PDF)

Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis

Journal of Crohn's and colitis, 2016-03, Vol.10 (3), p.330-337

2016

Volltextzugriff (PDF)

Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells

Clinical and experimental immunology, 2021-02, Vol.203 (2), p.304-314

2021

Volltextzugriff (PDF)

Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (2), p.179-189

2018

Volltextzugriff (PDF)

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

Multiple sclerosis journal - experimental, translational and clinical, 2019-10, Vol.5 (4), p.2055217319888767-2055217319888767

2019

Volltextzugriff (PDF)

The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

Journal of hepatology, 2017-02, Vol.66 (2), p.382-389

2017

Volltextzugriff (PDF)

Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample

European journal of clinical nutrition, 2017-08, Vol.71 (8), p.995-1001

2017

Volltextzugriff (PDF)

Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 2011-06, Vol.53 (6), p.1967-1976

2011

Volltextzugriff (PDF)

RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2019-01, Vol.9 (1), p.167, Article 167

2019

Volltextzugriff (PDF)

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry

HLA, 2017-10, Vol.90 (4), p.228-233

2017

Volltextzugriff (PDF)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis

JHEP reports, 2022-11, Vol.4 (11), p.100561-100561, Article 100561

2022

Volltextzugriff (PDF)

P1202 : Definition and comparative analysis of the T cell receptor repertoire in patients with primary sclerosing cholangitis

Journal of hepatology, 2015-04, Vol.62, p.S807-S807

2015

Volltextzugriff (PDF)

Agreement of a child's respiratory symptom diary with parental reports and peak expiratory flow

The international journal of tuberculosis and lung disease, 2009-03, Vol.13 (3), p.400

2009

Volltextzugriff (PDF)

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Nature communications, 2023-06, Vol.14 (1), p.3304-3304, Article 3304

2023

Volltextzugriff (PDF)

Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling

Nature metabolism, 2021-09, Vol.3 (9), p.1228

2021

Volltextzugriff (PDF)

Development of a high-resolution NGS-based HLA-typing and analysis pipeline

Nucleic acids research, 2015-06, Vol.43 (11), p.e70

2015

Volltextzugriff (PDF)

Gut microbiota diversity predicts immune status in HIV-1 infection

AIDS (London), 2015-11, Vol.29 (18), p.2409-2418

2015

Volltextzugriff (PDF)

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis

Gastroenterology (New York, N.Y. 1943), 2015-05, Vol.148 (5), p.924-927.e2

2015

Volltextzugriff (PDF)

Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens

The American journal of pathology, 2022-04, Vol.192 (4), p.629-641

2022

Volltextzugriff (PDF)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

PloS one, 2020-05, Vol.15 (5), p.e0232739-e0232739

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation

Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis

Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells

Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample

Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis

RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis

P1202 : Definition and comparative analysis of the T cell receptor repertoire in patients with primary sclerosing cholangitis

Agreement of a child's respiratory symptom diary with parental reports and peak expiratory flow

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling

Development of a high-resolution NGS-based HLA-typing and analysis pipeline

Gut microbiota diversity predicts immune status in HIV-1 infection

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis

Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

Suchergebnisse filtern